Demand for COVID-19 Drugs During the Early Phase of the Pandemic in Italy | Critical Care Medicine | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy

Educational Objective
To identify the key insights or developments described in this article

In February 2020, Italy was the first European country to detect coronavirus disease 2019 (COVID-19) in individuals and rapidly turned into one of the most-affected regions of the world. The National Health Service (NHS), which provides universal coverage to citizens, was challenged as never before in the history of the institution. Because no approved drug was available, patients received potentially effective drugs, participated in clinical trials, accessed compassionate drug use programs, or self-medicated.1 The aim of this study was to evaluate changes in drug demand during the early phase of the COVID-19 outbreak in Italy compared with the period before the outbreak.

Sign in to take quiz and track your certificates

Buy This Activity
Article Information

Accepted for Publication: December 21, 2020.

Published: February 8, 2021. doi:10.1001/jamanetworkopen.2020.37060

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Ammassari A et al. JAMA Network Open.

Corresponding Author: Adriana Ammassari, MD, Italian Medicines Agency, Via del Tritone, 181, 00187 Rome, Italy (a.ammassari@aifa.gov.it).

Author Contributions: Drs Ammassari and Di Filippo contributed equally to the study. Dr Di Filippo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Di Filippo, M.P. Trotta, F. Trotta, Magrini.

Acquisition, analysis, or interpretation of data: Ammassari, Di Filippo, Traversa, Pierantozzi, F. Trotta.

Drafting of the manuscript: Ammassari, M.P. Trotta.

Critical revision of the manuscript for important intellectual content: Ammassari, Di Filippo, Traversa, Pierantozzi, F. Trotta, Magrini.

Statistical analysis: Di Filippo, Pierantozzi.

Administrative, technical, or material support: Di Filippo.

Supervision: M.P. Trotta, Traversa, F. Trotta, Magrini.

Conflict of Interest Disclosures: None reported.

Additional Contributions: We thank all members of the Italian Medicines Agency Technical Scientific Committee, who provided scientific advice on emergency regulation for COVID-19 clinical trials and compassionate use. Claudia Biffoli, MSc, and Chiara Brutti, MSc (Italian Ministry of Health), provided raw data and did not receive compensation.

References
1.
Sanders  JM , Monogue  ML , Jodlowski  TZ , Cutrell  JB .  Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review.   JAMA. 2020;323(18):1824-1836. doi:10.1001/jama.2020.6019PubMedGoogle Scholar
2.
Vaduganathan  M , van Meijgaard  J , Mehra  MR , Joseph  J , O’Donnell  CJ , Warraich  HJ .  Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United States.   JAMA. 2020;323(24):2524-2526. doi:10.1001/jama.2020.9184PubMedGoogle ScholarCrossref
3.
Shehab  N , Lovegrove  M , Budnitz  DSUS .  US hydroxychloroquine, chloroquine, and azithromycin outpatient prescription trends, October 2019 through March 2020.   JAMA Intern Med. 2020;180(10):1384-1386. doi:10.1001/jamainternmed.2020.2594PubMedGoogle ScholarCrossref
4.
Addis  A , Genazzani  A , Trotta  MP , Magrini  N .  Promoting better clinical trials and drug information as public health interventions for the COVID-19 emergency in Italy.   Ann Intern Med. 2020;173(8):654-655. doi:10.7326/M20-3775PubMedGoogle ScholarCrossref
5.
Prentice  C , Chen  J , Stantic  B.   Timed intervention in COVID-19 and panic buying.   Journal of Retailing and Consumer Services. 2020;11(57):102203. doi:10.1016/j.jretconser.2020.102203Google Scholar
6.
Osservatorio Nazionale sull’Impiego dei Farmaci. Rapporto sull’uso dei farmaci durante l’epidemia COVID-19: luglio. 2020. Accessed December 06, 2020. https://www.aifa.gov.it/en/-/online-il-rapporto-sull-uso-dei-farmaci-durante-l-epidemia-covid-19
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close